A roadmap for personalized medicine: the findings of the IC2PerMed project

Flavia Beccia, Francesco Andrea Causio, Marzia Di Marcantonio, Ilda Hoxhaj, Chiara Cadeddu, Melissa Campagno, Lena Schleicher, Carmen Fotino, Maike K. Tauchert, Marta Lomazzi, Lili Wang, Wenya Wang, Huiyao Huang, Walter Ricciardi, Stefania BocciaFrontiers in Medicine 2025 · DOI

Abstract

A shared action plan can guide health policy and help policymakers understand the interconnection between healthcare, the economy, and society. By supporting international projects and investing in research and innovation, stakeholders can advance global healthcare.

Introduction

Personalized Medicine (PM)—the tailoring of treatment to an individual's genetic and lifestyle profile—is a global priority. However, its implementation is currently hindered by extreme fragmentation. The IC2PerMed project, an international effort between the European Union and China, establishes a strategic roadmap to bridge the gap between PM research and clinical implementation. These two regions represent major healthcare ecosystems operating under distinct regulatory and data-governance frameworks, such as the EU’s GDPR and China’s Data Security Law. The project addresses the "translational gap" where scientific breakthroughs in genomics often fail to become standard clinical practice due to a lack of shared data standards and inconsistent reimbursement models.

Methodology

The researchers employed a multi-phase, qualitative methodology to build consensus across borders. This process began with a mapping exercise and surveys of 47 international experts to review existing PM policies. The core of the study involved three separate, two-round Delphi surveys where experts rated the relevance of proposed priorities. Consensus was defined as ≥70% agreement. Finally, using thematic synthesis, the team consolidated 65 shared priorities into a roadmap structured around three pillars: sustainable healthcare, innovation and market, and research and clinical studies.

Methodological synthesis of the IC2PerMed Roadmap development process.

Key Insights and Results

The primary output is a Joint Roadmap that identifies data interoperability as a global utility. The roadmap advocates for "analyzable, comparable, and interoperable" data across borders, suggesting that mutual recognition of ethical standards is more critical than identical laws.

Key thematic areas identified include:

  • Health Literacy: PM requires "empowered citizens" and trained providers to interpret "omics" data.
  • Beyond Genetics: A shift toward integrating real-time data from IoT devices and environmental monitoring.
  • Economic Sustainability: PM solutions must undergo rigorous Health Technology Assessment (HTA) to prove economic value for public reimbursement.
Thematic categories for the roadmap pillars, including cost-effectiveness and data exchange.

A concrete result of this roadmap is the proposal to increase DPYD (pharmacogenomic) testing implementation from 20–30% to 70% by 2030 across EU and Chinese oncology centers. Additionally, the roadmap mandates the creation of federated data infrastructures to allow cross-border research while respecting national data sovereignty.

Limitations and Future Directions

While the IC2PerMed project successfully identified a shared "common ground," several limitations remain. There is currently a lack of a structured framework to evaluate the actual impact of the roadmap on patient outcomes. Furthermore, Delphi results were not clustered by country, preventing a deep dive into specific regional divergences. Future work will focus on developing an operational evaluation framework with key performance indicators (KPIs) to track the adoption of these roadmap actions by national programs.

Summary updated

Abstract

A shared action plan can guide health policy and help policymakers understand the interconnection between healthcare, the economy, and society. By supporting international projects and investing in research and innovation, stakeholders can advance global healthcare.
BibTeX
@inproceedings{beccia2025roadmap,
  author = {Flavia Beccia and Francesco Andrea Causio and Marzia Di Marcantonio and Ilda Hoxhaj and Chiara Cadeddu and Melissa Campagno and Lena Schleicher and Carmen Fotino and Maike K. Tauchert and Marta Lomazzi and Lili Wang and Wenya Wang and Huiyao Huang and Walter Ricciardi and Stefania Boccia},
  title = {{A roadmap for personalized medicine: the findings of the IC2PerMed project}},
  booktitle = {Frontiers in Medicine},
  year = {2025},
  doi = {10.3389/fmed.2025.1572921},
}
Figure